- Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference
- Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
- Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine
- Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
- Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
- Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
More ▼
Key statistics
On Friday, Arcturus Therapeutics Holdings Inc (ARCT:NMQ) closed at 31.82, -29.29% below its 52-week high of 45.00, set on Jun 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 41.98 |
---|---|
High | 42.42 |
Low | 29.73 |
Bid | 31.90 |
Offer | 31.91 |
Previous close | 42.60 |
Average volume | 743.50k |
---|---|
Shares outstanding | 26.93m |
Free float | 24.58m |
P/E (TTM) | -- |
Market cap | 1.12bn USD |
EPS (TTM) | -4.02 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼